Pavel Martasek Selected Research

Pavel Martasek Research Topics

Disease

4	Neoplasms (Cancer) 10/2022 - 08/2019
3	Acute Intermittent Porphyria (Porphyria, Acute) 04/2009 - 07/2008
2	Variegate Porphyria (Protoporphyrinogen Oxidase Deficiency) 01/2022 - 01/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2013 - 01/2012
2	Hepatolenticular Degeneration (Wilson's Disease) 05/2012 - 01/2011
2	Rett Syndrome (Rett's Disorder) 05/2010 - 01/2007
2	Hypoxia (Hypoxemia) 03/2009 - 03/2006
1	Renal Insufficiency (Renal Failure) 01/2022
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Photosensitivity Disorders (Photodermatitis) 08/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2018
1	Dementia (Dementias) 01/2018
1	Jaundice (Icterus) 05/2016
1	Chronic Idiopathic Jaundice (Dubin Johnson Syndrome) 05/2016
1	Antley-Bixler Syndrome Phenotype 01/2016
1	Congenital Abnormalities (Deformity) 01/2016
1	Atherosclerotic Plaque (Atheroma) 01/2013
1	Atherosclerosis 01/2012
1	Stable Angina 01/2012
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2010
1	Lichen Sclerosus et Atrophicus (Lichen Sclerosus) 08/2010
1	Hepatic Porphyrias (Hepatic Porphyria) 12/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2007
1	Neurodevelopmental Disorders 01/2007

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 01/2021 - 05/2007
4	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 08/2010 - 07/2008
3	SaltsIBA 10/2022 - 08/2019
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2009 - 03/2006
2	Apolipoproteins E (ApoE)IBA 01/2018 - 05/2010
2	PorphyrinsIBA 05/2016 - 04/2009
2	Heme Oxygenase-1IBA 01/2013 - 12/2010
2	CopperIBA 05/2012 - 01/2011
2	DNA (Deoxyribonucleic Acid)IBA 12/2009 - 04/2009
2	Heme (Haem)IBA 04/2009 - 07/2008
2	NitritesIBA 03/2009 - 03/2006
2	Nitric Oxide Synthase (NO Synthase)IBA 03/2009 - 05/2007
2	Protein Isoforms (Isoforms)IBA 03/2009 - 05/2007
1	Hemoglobins (Hemoglobin)IBA 01/2022
1	Protoporphyrinogen Oxidase (Protox)IBA 01/2022
1	CalciumIBA 01/2021
1	VPM chlorideIBA 08/2020
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 08/2020
1	Photosensitizing Agents (Photosensitizers)IBA 08/2020
1	Adenosine Triphosphate (ATP)IBA 08/2019
1	MelatoninIBA 01/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018
1	HomocysteineIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	BilirubinIBA 05/2016
1	coproporphyrin IIBA 05/2016
1	4,6-dinitro-o-cresol (DNOC)IBA 01/2016
1	NADPH-Ferrihemoprotein Reductase (Cytochrome P450 Reductase)IBA 01/2016
1	Apolipoproteins AIBA 01/2013
1	AntioxidantsIBA 05/2012
1	Ezetimibe (Zetia)FDA Link 01/2012
1	Atorvastatin (Lipitor)FDA Link 01/2012
1	LipidsIBA 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 04/2009
1	Acute Hepatic PorphyriaIBA 04/2009
1	Oxygen (Dioxygen)IBA 03/2009
1	ArgonIBA 03/2009
1	Nitrite Reductases (Nitrite Reductase)IBA 03/2009
1	Methyl-CpG-Binding Protein 2IBA 01/2007
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 03/2006
1	AnionsIBA 03/2006
1	Arginine (L-Arginine)FDA Link 03/2006

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2012